Your institution may have access to this item. Find your institution then sign in to continue.
Title
Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03
Authors
D'Addario, G.; Rauch, D.; Stupp, R.; Pless, M.; Stahel, R.; Mach, N.; Jost, L.; Widmer, L.; Tapia, C.; Bihl, M.; Mayer, M.; Ribi, K.; Lerch, S.; Bubendorf, L.; Betticher, D.C.